期刊
JOURNAL OF CHEMICAL NEUROANATOMY
卷 127, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jchemneu.2022.102191
关键词
Basal ganglia; 6-hydroxydopamine (6-OHDA); Parkinson ?s disease (PD); L-dopa-induced dyskinesia (LID); Laser microdissection
In Parkinson's disease, decreased dopamine levels in the striatum lead to abnormal circuit activity in the basal ganglia, resulting in increased output via the substantia nigra pars reticulata. NMDA receptor hyperactivity is a characteristic feature of basal ganglia circuitry under conditions of dopamine depletion. The study focused on Asc-1 as a factor regulating NMDA receptor activity by modulating D-serine and glycine concentration. Different regulation of Asc-1 mRNA expression in basal ganglionic nuclei was observed in response to striatal dopamine concentration, and Asc-1 may be a therapeutic target for motor symptoms in Parkinson's disease.
In Parkinson's disease (PD), a decrease in dopamine levels in the striatum causes abnormal circuit activity in the basal ganglia, resulting in increased output via the substantia nigra pars reticulata (SNr). A characteristic feature of glutamatergic synaptic transmission in the basal ganglia circuitry under conditions of dopamine depletion is enhanced synaptic activity of NMDA receptors. However, the cause of this NMDA receptor hyperactivity is not fully understood. We focused on Asc-1 (SLC7A10), an alanine-serine-cysteine transporter, as one of the factors that regulate NMDA receptor activity by modulating D-serine and glycine concentration in synaptic clefts. We generated PD model mice by injection of 6-hydroxydopamine into the unilateral medial forebrain bundle and analyzed the expression level of Asc-1 mRNA in the nuclei of basal ganglia (the external segment of the globus pallidus (GPe), subthalamic nucleus (STN), and SNr) compared to control mice. Each nucleus was dissected using laser microdissection, and RNA was extracted and quantified by quantitative PCR. Asc-1 mRNA expression was significantly higher in the GPe and lower in the SNr under the PD state than that in control naive mice. The STN showed no change in Asc-1 mRNA expression. We further modeled L-dopa-induced dyskinesia by administering L-dopa continuously for 14 days to the PD model mice and found that Asc-1 mRNA expression in the GPe and SNr became close to that of control mice, regardless of the presence of abnormal involuntary movements. The present study revealed that Asc-1 mRNA expression is differentially regulated in the basal ganglionic nuclei in response to striatal dopamine concentration (depleted or replenished) and suggests that Asc-1 can be a therapeutic target for the amelioration of motor symptoms of PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据